SavedAdd your journal

Journals / Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi / 2017 / Cilt: 14 - Sayı: 2

Systemic Methotrexate and Vaginal Misoprostol Treatment In Cesarean Scar Pregnancy: A Case Report

Sezaryen Skar Gebeliğinde Sistemik Metotreksat ve Vajinal Misoprostol Tedavisi: Bir Olgu Sunumu

Ali YAVUZCAN
Mete ÇAĞLAR
Alper BAŞBUĞ
Esma YILDIRIM
Sıtkı ÖZBİLGEÇ
Pages
89–91
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The reandomized comprehensive studies are needed to reveal the reliability of a single dose of MTX and misoprostol combination therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cesarean scar pregnancy CSP is a rare kind of ectopic pregnancy caused by the implantation of the gestational sac on cesarean section scar.
📊
Key Findings & Data:CSP can cause massive bleeding and uterine rupture.
💡
Conclusion & Impact:The reandomized comprehensive studies are needed to reveal the reliability of a single dose of MTX and misoprostol combination therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Metotreksat · misoprostol · sezaryen skar gebeliği

Abstract

Cesarean scar pregnancy CSP is a rare kind of ectopic pregnancy caused by the implantation of the gestational sac on cesarean section scar. CSP can cause massive bleeding and uterine rupture. Due to the lack of prospectiver and omized controlled studies on CSP; there is no clear consensus about diagnosis and treatment. In this report, a CSP case reported, treated with single dose methotrexate MTX and vaginal misoprostol combination. Although; single- dose MTX and vaginal misoprostol combination was successful in our patient, the patients should be monitored carefully during this treatment against silent rupture and massive hemorrhage. The reandomized comprehensive studies are needed to reveal the reliability of a single dose of MTX and misoprostol combination therapy.

Özet

Sezaryen skar gebeliği SSG gestasyonel kesenin geçirilmiş sezaryen skarına implante olmasıyla ortaya çıkan nadir bir ektopik gebelik çeşididir. SSG masif hemoraji ve uterinrüptüre neden olabilir. SSG’nin ile ilgili çok sayıda prospektifr andomize kontrollü çalışmanın bulunmaması nedeniyle tanı ve tedavisi ile net bir konsensüs yoktur. Bu raporda tek doz sistemik metotreksat MTX ve vajinal misoprostol ile tedavi edilen SSG olgusu sunulmuştur. Tek doz MTX ve vajinal misoprostol kombinasyon tedavisi olgumuzda başarıyla sonuçlanmış olsa da sessiz rüptür veya masif hemoraji riskine karşı hastalar dikkatli şekilde takip edilmelidir. Tek doz MTX ve misoprostol kombinasyon tedavisinin güvenilirliğinin tam olarak ortaya konabilmesi için kapsamlı randomize çalışmalara gereksinim vardır.

🔖

Cite This Article

YAVUZCAN, A., ÇAĞLAR, M., BAŞBUĞ, A., YILDIRIM, E., ÖZBİLGEÇ, S. (2022). Systemic Methotrexate and Vaginal Misoprostol Treatment In Cesarean Scar Pregnancy: A Case Report. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, Cilt: 14 - Sayı: 2, 89–91. https://ajindex.com/articles/558729

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Liu W, Shen L, Wang Q, Wang W, Sun Z. Uterine artery embolization combined with curettage vs. methotrexate plus curettage for cesarean scar pregnancy. Arch Gynecol Obstet 2015 Nov 18. Seow KM, Huang LW, Lin YH et al. Cesarean scar pregnancy: issues in management. Ultrasound Obstet Gynecol 2004; 23: 247–53.
  2. Mutlu İ, Mutlu MF, Erdem A, Bulut B, Erdem M. Sezaryen Skar Gebeliğinin Tek Doz Lokal Metotreksat Uygulaması ile Tedavisi: Olgu Sunumu. Gazi Medical Journal 2015; 26: 119-20.
  3. Vial Y, Petignat P, Hohlfeld P. Pregnancy in a cesarean scar. Ultrasound Obstet Gynecol 2000; 16: 592–3.
  4. Karakuş S, Yıldız Ç, Akkar ÖB, Çetin M. Sezaryen Skar Gebeliği: İki Olgu Nedeniyle. Cumhuriyet Tıp Derg 2014; 36: 558-61.
  5. Riaz RM, Williams TR, Craig BM, Myers DT. Cesarean scar ectopic preg- nancy: imaging features, current treatment options, and clinical outco- mes. Abdom Imaging. 2015;40:2589-99.
  6. Gemzell-Danielsson K, Ho PC, GómezPonce de León R, Weeks A, Wi- nikoff B. Misoprostol to treat missed abortion in the first trimester. Int J Gynaecol Obstet 2007; 99:182-5.
  7. Ouyang Y, Li X, Yi Y, Gong F, Lin G, Lu G. First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilizati- on-embryo transfer: a retrospective clinical analysis of 12 cases. Reprod Biol Endocrinol 2015 21;13:126. Cheng PJ, Chueh HY, Soong YK. Sonographic diagnosis of a uterine de- fectin a pregnancy at 6 weeks’ gestation with a history of curettage. Ultrasound Obstet Gynecol 2003;21:501–3.
  8. Tower AM, Frishman GN. Cesarean scar defects: an under recognized cause of abnormal uterine bleeding and other gynecologic complicati- ons. J Minim Invasive Gynecol 2013;20:562-72.
  9. Rajakumar C, Agarwal S, Khalil H, Fung Kee Fung KM, Shenassa H, Singh SS. Caesarean scar pregnancy. J Obstet Gynaecol Can 2015;37:199– 200. Jurkovic D, Hillaby K, Woelfer B, et al. First-trimester diagnosis and ma- nagement of pregnancies implanted in to the lower uterine caesarean section scar. Ultrasound Obstet Gynecol 2003;21:220–7.
  10. Zhang Y, Gu Y, Wang JM, Li Y.Analysis of cases with cesarean scar preg- nancy. J Obstet Gynaecol Res 2013;39:195-202.
  11. Liu H, Leng J, Shi H, Lang J. Expectant treatment of cesarean scar preg- nancy: two case reports and a glimpse at the natural courses. Arch Gy- necol Obstet 2010 Oct;282:455-8.
  12. Kutuk MS, Uysal G, Dolanbay M, Ozgun MT. Success fulmedical tre- atment of cesarean scar ectopic pregnancies with systemic multi dose methotrexate: single-center experience.J Obstet Gynaecol Res